145 related articles for article (PubMed ID: 7921203)
41. Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives.
Hirohara D; Nomura K; Okamoto T; Ujihara M; Takano K
J Clin Endocrinol Metab; 2001 Sep; 86(9):4292-8. PubMed ID: 11549664
[TBL] [Abstract][Full Text] [Related]
42. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M
J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780
[No Abstract] [Full Text] [Related]
43. Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.
Rossi GP; Ganzaroli C; Cesari M; Maresca A; Plebani M; Nussdorfer GG; Pessina AC
Cardiovasc Res; 2003 Jan; 57(1):277-83. PubMed ID: 12504838
[TBL] [Abstract][Full Text] [Related]
44. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
Woodland E; Tunny TJ; Hamlet SM; Gordon RD
Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
[TBL] [Abstract][Full Text] [Related]
45. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
Uchida K; Morimoto S; Takeda R; Murakami M
Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
[No Abstract] [Full Text] [Related]
46. Regulation of aldosterone secretion in primary aldosteronism.
Vetter H; Vetter W
Horm Metab Res; 1975 Sep; 7(5):418-24. PubMed ID: 1183923
[TBL] [Abstract][Full Text] [Related]
47. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
[TBL] [Abstract][Full Text] [Related]
48. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
[TBL] [Abstract][Full Text] [Related]
50. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
Skrabal F; Mauser R
Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
[TBL] [Abstract][Full Text] [Related]
51. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
[TBL] [Abstract][Full Text] [Related]
52. A German family with glucocorticoid-remediable aldosteronism.
Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
[TBL] [Abstract][Full Text] [Related]
53. Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity.
Oelkers W
Acta Endocrinol (Copenh); 1985 Jan; 108(1):91-7. PubMed ID: 2982239
[TBL] [Abstract][Full Text] [Related]
54. Plasma atrial natriuretic peptide (ANP) in primary aldosteronism.
Chen JH; Tsai JH; Lai YH; Hwang SJ
Taiwan Yi Xue Hui Za Zhi; 1988 Sep; 87(9):851-6. PubMed ID: 2975697
[No Abstract] [Full Text] [Related]
55. Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.
Rye P; Chin A; Pasieka J; So B; Harvey A; Kline G
J Clin Hypertens (Greenwich); 2015 Jul; 17(7):541-6. PubMed ID: 25756935
[TBL] [Abstract][Full Text] [Related]
56. Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
Hoefnagels WH; Drayer JI; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1980 Dec; 51(6):1330-4. PubMed ID: 7440698
[TBL] [Abstract][Full Text] [Related]
57. Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
Myśliwiec J; Zukowski Ł; Grodzka A; Piłaszewicz A; Dragowski S; Górska M
J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):367-71. PubMed ID: 22406967
[TBL] [Abstract][Full Text] [Related]
58. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
Nicholls MG; Espiner EA; Donald RA
J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213
[TBL] [Abstract][Full Text] [Related]
59. Primary aldosteronism -- screening, diagnosis and therapy.
Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
[TBL] [Abstract][Full Text] [Related]
60. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
